Yüklüyor......
New developments in the treatment of chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemia
Although imatinib revolutionized the management of chronic myeloid leukemia (CML), recent data indicate a transformation in the treatment approach likely in the near future. The superiority of second-generation tyrosine kinase inhibitors (TKIs) over imatinib in newly diagnosed disease has been recog...
Kaydedildi:
| Yayımlandı: | Leuk Lymphoma |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5681224/ https://ncbi.nlm.nih.gov/pubmed/21299461 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2010.546917 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|